Navigation Links
Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial
Date:1/16/2012

rug Administration (FDA) approval of the Epic Stent system, which was submitted to the FDA in September 2011. 

The Epic Nitinol Stent System received CE Mark approval and was launched in Europe and other international markets in 2009.  In the U.S, it is an investigational device, limited by applicable law to investigational use only and not available for sale.

About Boston ScientificBoston Scientific is a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties.  For more information, please visit: www.bostonscientific.com.Cautionary Statement Regarding Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words.  These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance.  These forward-looking statements include, among other things, statements regarding regulatory approvals, clinical trials, product performance and competitive offerings.  If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements.  These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release.  As a r
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... -- Research and Markets ( ... "Investigation Report on China,s Latanoprost Market, 2010-2019" ... by Pharmacia & Upjohn in 1995, latanoprost is ... intraocular pressure. As the first pressure- lowering prostaglandin ... of Xalatan) entered China ...
(Date:8/28/2015)... 2015 Perrigo Company plc ("Perrigo") (NYSE: ... ("Mylan") (NASDAQ: MYL ) shareholder vote regarding its ... views of Mylan,s offer to Perrigo shareholders have always ... Board,s careful reflection of the value available to Perrigo ... that Mylan has allowed its shareholders to consider," said ...
(Date:8/28/2015)... , Joint research by Prof. Kim ... , Published in ,Stem Cells Translational Medicine, (IF ... multiple IV administration of Adipose-derived MSC , Increase ... , Commercialization within 5 years expected ... adult mesenchymal stem cells (MSCs) may extend healthy life ...
Breaking Medicine Technology:China Latanoprost Market Investigation Report 2015-2019 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... abuse, or those who might personally be struggling with chemical dependency, may be ... from Best Drug Rehabilitation, a results-driven holistic treatment center for addiction located in ...
(Date:8/28/2015)... ... 28, 2015 , ... Drugs and alcohol abuse by employees ... new approach on solutions in his new book ":Unraveling The Psychological Mystery of ... together for meaningful group meetings. "This would educate the employees on not ...
(Date:8/28/2015)... ... August 28, 2015 , ... Dr. Gregory K. Toumayan, D.C., Q.M.E., is now ... shoulder pain, hip pain, neck pain, stiffness, muscle spasms, and numbness. ... of Illinois, and then went on to earn his title of Doctor of Chiropractic ...
(Date:8/28/2015)... ... August 28, 2015 , ... Mendon, IL, home of the Adams County Fairgrounds, ... all for a good cause. In its second year, the “Music With A Mission” ... Drug Rehabilitation. The “Mission” of “Music With A Mission” is to raise money to ...
(Date:8/28/2015)... ... 28, 2015 , ... The newest therapy to receive orphan drug status for ... time soon, according to educational website Surviving Mesothelioma. Click here to read their ... for mesothelioma last week from the FDA, will now head into Phase I clinical ...
Breaking Medicine News(10 mins):Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2Health News:Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article 2
... Dec. 1 MassMutual Retirement Services Division has added ... Nonprofit activity has more than tripled in 2008 compared ... Dan Darby joined MassMutual on December 1 ... reports to M. Palmer Whitney, national managing director, nonprofit ...
... 1 The Food Allergy & Anaphylaxis Network (FAAN) ... CEO, replacing Founder Anne Munoz-Furlong, who is retiring. , ... to FAAN extensive knowledge of anaphylaxis, a severe, potentially ... Senior Director of Marketing, she led the marketing team ...
... supplements can also trigger acute organ failure, study says ... the single largest class of drugs that cause idiosyncratic ... accounts for about 13 percent of cases of acute ... most common cause of death from acute liver failure. ...
... Dry-needling, steroids effective against plantar fasciitis, researchers say ... researchers say they,ve developed a fast, effective, non-invasive ... plantar fasciitis. , Using a combination of "dry-needling" ... say their approach achieved a 95 percent success ...
... as one in five of all Americans who survive a ... emotionally paralyzed survivors of 9/11 and broken up survivors, families. ... lower the chance of developing the disorder, but thanks to ... PTSD may be just around the corner. , Prof. Joseph ...
... will die of AIDS. In fact, nearly 7,000 people die each day ... 1 is World AIDS Day, a day of awareness and outreach to help ... Day 2008 is You Can Make a Difference and ... as well as helping dispel the myths and misconceptions about HIV. , ...
Cached Medicine News:Health News:MassMutual Retirement Services Adds Two to Nonprofit Sales Team 2Health News:MassMutual Retirement Services Adds Two to Nonprofit Sales Team 3Health News:FAAN Names New CEO 2Health News:Antibiotics Largest Cause of Drug-Induced Liver Damage 2Health News:New Twist on Treatment of Foot Pain 2Health News:New Twist on Treatment of Foot Pain 3Health News:Easing the stress of trauma 2Health News:In Support of World AIDS Day, FHSSA Announces New Partnerships That Include the First In-Country Partnerships in Namibia and The Gambia 2
A budget-priced microscope designed for ENT and neuro surgery....
The OPMI Neuro/NC4 System is the system of choice for integration with every major Image Guided Surgery (IGS). It can be mounted on NC4 floorstand or ceiling mount....
... microscope system has been designed ... fatigue. The maneuverability of this ... provides fatigue-free viewing even at ... as in posterior fossa, cerebral ...
... The XL Advantage delivers higher magnification ... a crisp, true image, even at the ... to edge clarity and precise color rendition ... treated with an anti-reflective coating produce a ...
Medicine Products: